| 标题 |
Long‐term safety and efficacy of the sodium–glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52‐week open‐label, multicenter, post‐marketing clinical study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Diabetes Investigation 作者:Yasuo Terauchi; Hisataka Fujiwara; Yuji Kurihara; Hideki Suganami; Masahiro Tamura; et al 出版日期:2019-05-28 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)